Qiagen NV (WBO:QGE3) Accounts Payable & Accrued Expense : €423 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Accounts Payable & Accrued Expense?

Qiagen NV's quarterly accounts payable & accrued expense declined from Sep. 2024 (€411 Mil) to Dec. 2024 (€269 Mil) but then increased from Dec. 2024 (€269 Mil) to Mar. 2025 (€423 Mil).

Qiagen NV's annual accounts payable & accrued expense declined from Dec. 2022 (€285 Mil) to Dec. 2023 (€261 Mil) but then increased from Dec. 2023 (€261 Mil) to Dec. 2024 (€269 Mil).

Qiagen NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for Qiagen NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Accounts Payable & Accrued Expense Chart

Qiagen NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

271.11

289.20

284.67

260.97

269.09

Qiagen NV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															399.87	503.72	410.81	269.09	423.22

Qiagen NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Qiagen NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE3) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Headlines

No Headlines